Intramuscular injection of bone marrow mononuclear cells (BMMNC) vs control
Complications and side effects · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes side effects and complications ( compared with control (very low certainty).
1 finding from 1 review
- Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia 2022 · Cochrane Headline outcomes onlyRR 2.13 [0.5, 8.97]4 studies · 176 participantsVery low